List of analytes measured in SFEM II baseline media
| Analytes undetected . | Analytes detected . | Concentration (pg/mL) . |
|---|---|---|
| GM-CSF, IL-9 | GRO-α | Below LLOD |
| IL-1β, IFN-α | EGF | Below LLOD |
| IL-1α, IL-15 | FGF-2 | Below LLOD |
| IL-12p70, IL-31 | IFN-γ | Below LLOD |
| IL-2, IL-7 | IL-8 | Below LLOD |
| Il-4, TNF-β | IL-18 | Below LLOD |
| IL-5, SCF | IL-13 | Below LLOD |
| TNF-α, IP-10 | IL-1RA | 75 ± 58 |
| IL-17A, PDGF-BB | LIF | 19 ± 2 |
| IL-21, IL-6 | HGF | 80 ± 25 |
| IL-22, IL-10 | NGF | 28 ± 2 |
| IL-23, MIP-1α | VEGF-A | 9.7 ± 1.4 |
| IL-27, MIP-1β | VEGF-D | 36 ± 3 |
| SDF-1α, MCP-1 | — | — |
| Eotaxin, RANTES | — | — |
| Analytes undetected . | Analytes detected . | Concentration (pg/mL) . |
|---|---|---|
| GM-CSF, IL-9 | GRO-α | Below LLOD |
| IL-1β, IFN-α | EGF | Below LLOD |
| IL-1α, IL-15 | FGF-2 | Below LLOD |
| IL-12p70, IL-31 | IFN-γ | Below LLOD |
| IL-2, IL-7 | IL-8 | Below LLOD |
| Il-4, TNF-β | IL-18 | Below LLOD |
| IL-5, SCF | IL-13 | Below LLOD |
| TNF-α, IP-10 | IL-1RA | 75 ± 58 |
| IL-17A, PDGF-BB | LIF | 19 ± 2 |
| IL-21, IL-6 | HGF | 80 ± 25 |
| IL-22, IL-10 | NGF | 28 ± 2 |
| IL-23, MIP-1α | VEGF-A | 9.7 ± 1.4 |
| IL-27, MIP-1β | VEGF-D | 36 ± 3 |
| SDF-1α, MCP-1 | — | — |
| Eotaxin, RANTES | — | — |
EGF, epidermal growth factor; FGF, fibroblast growth factor; GRO-α, CXCL1 or chemokine C-X-C motif ligand; HGF, hepatocyte growth factor; LIF, leukemia inhibitory factor; LLOD, lower limit of detection; MCP-1, CCL2 (monocyte chemotatic protein 1); MIP-1α, CCL3 or chemokine (C-C motif) ligand; MIP-1β, CCL4 or chemokine (C-C motif) ligand; NGF, nerve growth factor; RANTES, regulated on activation, normal T cells expressed or secreted (or CCL5); SDF, stromal-cell–derived factor; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.